Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

PDA launches anti-racist pharmacy toolkit

The Pharmacists' Defence Association's anti racist pharmacy toolkit was launched at the 2022 Clinical Pharmacy Congress.

The event also included a demonstration of how members could use the toolkit to work together to address inequality and discrimination in their workplace.


Elsy Gomez Campos, president of the PDA BAME Pharmacists’ Network, gave an overview of issues raised by network members as well as broader professional issues including over-representation of BAME pharmacists in fitness to practice complaints, under-representation of BAME pharmacists in leadership roles, limited access to post-graduate education, and bullying and discrimination in the workplace.

She concluded her opening statement by reminding members of what an exemplary pharmacy profession should look like which is about “being treated fairly and being offered the same opportunities to those that do not look like us.”

Manuella Asso, organising assistant and PDA BAME Pharmacists’ Network coordinator, explained that the toolkit for was representatives, members, and other pharmacists to assess their workplaces and to help them take collective action to create an anti-racist workplace culture and environment.

She explained the PDA’s approach to the toolkit, which is based on Roger Kline’s 'No More Tick Boxes' research and uses PIPOW, a proven trade union organising framework that sets out a practical approach to support members to come together, assess their employer, and decide which areas in their workplace requires work.

Manuella said: “The toolkit can be adapted in different pharmacy settings, as the issues, evidence, and approach will vary from one employer to another. It’s important for members to collectively address issues at their employer.”

Angela Chiweshe, a member of the BAME Pharmacists’ Network, said: “The event was informative, I left feeling optimistic that tools are going to be made available to address some of the inequalities faced by pharmacists and to ensure that we are progressing as a profession, embracing diversity and encouraging transparency in our workplaces.”

Edwin Panford-Quainoo, another member, added: “I was really impressed with the toolkit and especially the fact that it can be applicable in multiple settings. It is well thought through and easy to follow. It is essential that the newly qualified pharmacists especially are supported through its use and application and get feedback from them as well. I can certainly see it evolving but the beginnings look very promising.

More For You

NHS app to boost clinical trials

The focus is on encouraging people from underrepresented groups, including minorities from African and Asian heritage, to sign up for clinical trials.

iStock

Government to use NHS app to boost clinical trials

The government’s 10-Year Health Plan is expected to provide a fillip to clinical trials, and it plans to make use of the NHS App to encourage people to sign up as participants.

People will be able to sign up for the NIHR Be Part of Research service (bepartofresearch.uk) on the NHS App for the trials best suited to their interests and needs.

Keep ReadingShow less
US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less
Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less